The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma.
 
Friedrich Foerster
Honoraria - Lilly; Pfizer; Roche
 
Roman Kloeckner
Consulting or Advisory Role - Boston Scientific; Bristol-Myers Squibb; Guerbet; Roche
Speakers' Bureau - Bristol-Myers Squibb; BTG; Guerbet; Siemens Healthineers
 
Maria Reig
No Relationships to Disclose
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; MSD
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology
Research Funding - Eisai; Ipsen
 
Jin Wook Chung
No Relationships to Disclose
 
Philippe Merle
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Merck; Roche
Consulting or Advisory Role - Bayer Schering Pharma
 
Joong-Won Park
Honoraria - Bayer; Eisai; Ipsen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Fabio Piscaglia
Consulting or Advisory Role - Alkermes; AstraZeneca; Bayer; Eisai; GE Healthcare; Ipsen; Roche; Roche; Tiziana Life Sciences
Speakers' Bureau - BMS; Bracco Diagnostics; Eisai; ESAOTE; MSD; Samsung
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Vincent Gaillard
Employment - Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Jordi Bruix
Consulting or Advisory Role - Arqule; Basilea; Bayer Schering Pharma; Bristol-Myers Squibb; BTG; Eisai; Novartis; Roche; Sirtex Medical
Speakers' Bureau - Bayer Schering Pharma
Research Funding - Bayer Schering Pharma (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen
 
Peter R. Galle
Honoraria - Adaptimmune; AstraZeneca/MedImmune; Bayer Schering Pharma; Boston Scientific; Bristol-Myers Squibb; Guerbet; Ipsen; Lilly; MSD; Roche/Genentech; Sirtex Medical
Consulting or Advisory Role - Adaptimmune; Bayer Schering Pharma; Boston Scientific; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; Sirtex Medical
Speakers' Bureau - Bayer Schering Pharma; Ipsen; Lilly; Roche
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Bayer Schering Pharma; Lilly; Sirtex Medical